The agreement now includes distribution of Roche's Kapa Biosystems portfolio in all geographies except the US, Brazil, and Japan.
Under the terms of the deal, Color Genomics will integrate Kapa Biosystems' library construction reagents into its NGS workflow.
The certification enables the reagent maker to create optimizing products for use beyond the research market.
Kapa offers "essential components" to Roche's overall NGS solution and enables Roche to improve the workflow of its NGS platforms.
Roche said the acquisition will strengthen its next-generation sequencing product offerings.
Kapa will supply DNA library prep reagents for 10X's GemCode platform to enable a more streamlined workflow and higher quality sequencing data.
Kapa will manufacture versions of its RNA-seq kits for distribution with Roche's RNA target enrichment system.
The firm will transition from its current partnership with Anachem to a direct sales and support channel in the UK as it expands its European operations.
NEW YORK (GenomeWeb) — Kapa Biosystems said today that it has signed a three-year exclusive distribution agreement with Nippon Genetics.
In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.
Technology Review points out that a new US presidential science advisor hasn't been selected.
Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.
President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.